The recent global monkeypox (mpox) outbreak, with a new and aggressive variant, has underscored the dire need for safe, broadly effective, and accessible vaccines. The LC16m8 vaccine, an attenuated ...

Therapies involving mRNA, a key to Covid vaccines, hold great potential in treating several diseases, but some lawmakers want ...

Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...

The world market for recombinant proteins remains strong, with North America and Europe dominating research and development as a result of their strong biopharmaceutical industries. The Asia-Pacific ...

WEHI scientists have uncovered a promising new way to enhance the effectiveness of vaccines by tapping into the potential of a specific type of immune cell, opening the door to long-lasting vaccines ...

It folds the genetic material DNA into desired shapes to isolate only the cells affected by the hard-to-treat pancreatic cancer and to create cancer vaccines that enhance the body's immunity.

(F) The change of total SIV DNA copies between pre-ART and viral rebound ... divided into five groups to evaluate the immunogenicity of the recombinant HSV-vector-based SIV vaccine. During the initial ...

Then, we constructed the recombinant HSV-ΔICP34.5 expressing simian immunodeficiency virus (SIV) env, gag, or the fusion antigen sPD1-SIVgag as a therapeutic vaccine, aiming to achieve a functional ...

We discuss inactivated vaccines, virally and bacterially vectored vaccines, recombinant protein and DNA vaccines, as well as the use of attenuated vaccines. Data regarding the correlates of ...

World Vaccine Congress 2025 presentation, What if Delivery Is the Missing Link in Cancer Immunotherapy? Insights from DNA Cancer Vaccine Trials Using Needle-Free Injection Delivery, will highlight ...

Current techniques of gene transfer in mammals include packaging the DNA into recombinant viral vectors ... to test if they have created an effective vaccine. In addition, naked DNA vaccines ...

Easier to produce than egg-based vaccines The vaccine is what's known as a recombinant protein vaccine. Unlike currently approved vaccines, which use live or dead versions of H5N1, it relies on ...